One of the earliest neuropathological events in Alzheimer's disease is accumulation of astrocytes at sites of Aβ 1-42 depositions. Our results indicate that Aβ 1-42 toxic peptide increases lipid peroxidation, apoptosis and cell death in neurons but not in astrocytes in primary culture. Aβ 1-42 -induced deleterious neuronal effects are not present when neurons and astrocytes are mixed cultured. Stimulation of astrocytes with toxic Aβ 1-42 peptide increased p-65 and decreased IκB resulting in inflammatory process. In astrocytes Aβ 1-42 decreases protein expressions of sirtuin 1 (SIRT-1) and peroxisome proliferator-activated receptor γ ( PPAR-γ) and over-expresses peroxisome proliferator-activated receptor γ coactivator 1 (PGC-1) and mitochondrial transcription factor A (TFAM), protecting mitochondria against Aβ 1-42 -induced damage and promoting mitochondrial biogenesis. In summary our data suggest that astrocytes may have a key role in protecting neurons, increasing neural viability and mitochondrial biogenesis, acquiring better oxidative stress protection and perhaps modulating inflammatory processes against Aβ 1-42 toxic peptide. This might be a sign of a complex epigenetic process in Alzheimer's disease development.
Introduction
The metabolic processing of the amyloid precursor protein (APP) produces mainly two peptide fractions of amyloid β peptide (Aβ), Aβ and Aβ . The accumulation and precipitation of Aβ peptide has been suggested as a neuropathological event associated with the progress and development of Alzheimer's disease (AD) [1, 2] . Extracellular Aβ deposits can cause oxidative stress, inflammation and mitochondrial dysfunction [3, 4, 5] . It has been shown in vitro and in vivo studies that the Aβ 1-42 enters the mitochondria causing an increase in reactive oxygen species, interruption of the electron transport chain and blockade of the ATP production [6, 7] . A deficiency in the function of the mitochondrial respiratory chain could affect the survival of cells associated with AD resulting in adverse impact for long-term health [8] . Moreover extracellular Aβ1-42 peptide induces oxidative stress and causes damage to mitochondrial DNA (mtDNA) which encodes the 13 key subunits of the respiratory chain, essential for respiratory function, susceptible to oxidative damage [9, 10] . The mtDNA maintenance, including nucleotide formation as well as mtDNA stabilization and transcription is in charge of mitochondrial transcription factor A (TFAM) [11] . Recent studies have indicated that TFAM and PGC-1 over-expression may inhibit mitochondrial
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Glial cells interact with Aβ and support neurons, but whether astrocytes could participate in regulating the Aβ-induced brain damage is, at the moment, poorly known. Here we evaluated the role of astrocytes in the neuro-toxic effects of Aβ peptides. For this purpose we used p r i m a r y a strocytes, neurons and mixed-cultures in the absence and in the presence of toxic Aβ1-42 peptide or non-toxic Aβ 40-1 (control) peptide. Our results demonstrate that Aβ 1-42 (5 µM) induces apoptotic cell death in neurons. However in mixed-cultures, astrocytes protect neurons against Aβ 1-42 -induced toxicity. Mechanistically astrocytes-induced neuron protection involves over-expression of TFAM and PGC-1, and decrease in PPAR-γ and SIRT-1.
Experimental Procedures
Materials 3-(4,5-dimethyl-2-thiazolyl)-2,5-dipheniyl-2H-tetrazolium bromide (MTT) was obtained from Sigma Chemical Co. (St Louis, MO). Dulbecco's modified Eagle's medium (DMEM) and foetal bovine serum (FBS) were obtained from Gibco (Gibco Invitrogen Corporation, Barcelona, Spain). Western Blot Chemiluminescent Detection System (ECL) was from Amersham (Amersham Biosciences, Barcelona, Spain). Antibodies: monoclonal anti-cytochrome c antibody (anti-Cytochrome c) (1:500), polyclonal anti-manganese superoxide dismutase (anti-MnSOD) (1:250), monoclonal anti-p65 (1:250), monoclonal anti-PGC-1 (1:250), monoclonal anti-TFAM (1:250), monoclonal anti-IκB (1:250), polyclonal anti-PPAR-γ (1:300), monoclonal anti-SIRT-1 (1:250), and monoclonal anti-tubuline (1:3000) antibodies (Sigma Aldrich, Madrid, Spain) were used. All other reagents were of analytical or culture grade purity. The oligomers Aβ (40-1 and 1-42), were prepared following manufacture instructions such as indicates Sigma-Aldrich biotechnology. Briefly, the peptides were dissolved in H2O and for assembly the oligomer preparations were heated for 24 h at 37ºC.
Primary culture of cortical astrocytes
All animals were handled according to the rules established by the bioethics committee of the School of Medicine, University of Valencia, Spain. Cerebral cortical astrocytes were isolated from rat fetuses of 21 days gestation. Fetuses were obtained by cesarean section and decapitated. Cerebral cortices were removed and cut into 1mm cubes and triturated 10-15 times through a Pasteur pipette. After centrifugation at 1000 rpm for 5 min the pellet was resuspended in DMEM containing 20% fetal bovine serum (FBS), supplemented with L-glutamine (1%), HEPES (10 mM), fungizone (1%), and antibiotics (1%). Cells were plated on T75 culture flask pretreated with poli-L-lysine. Cultures were maintained in a humidified atmosphere of 5% CO2/95% air at 37°C and allowed to grow to confluence and used at 15-20 days in vitro. After 1week of culture, the FBS content was reduced to 10%, and the medium was changed twice a week. The purity of astrocytes was assessed by immunofluorescence using anti-glial fibrillary acidic protein (anti-GFAP, astrocyte marker: Sigma-Aldrich, Madrid, Spain), anti-CD-68 (microglial marker: Serotec, Kidlington, UK), anti-myelin basic protein (oligodendroglial marker; Sigma-Aldrich, Madrid, Spain) and anti-microtubule-associated protein 2 (anti-MAP2, neuronal marker; Sigma-Aldrich, Madrid, Spain). The astrocytes were found to be at least 99% glial fibrillary acidic protein positive. No cells were found to express CD-68, myelin basic protein or microtubule-associated protein-2. For all of the experiments we used toxin-free sterile culture materials.
Neurons and neurons-astrocytes mixed cultures
Cerebral cortical neurons were isolated from rat fetuses of 14 or 15 days gestation. Briefly, cerebral cortices were removed and dissociated mechanically, by pipetting 10 times with 10ml DMEM. The cell suspension was filtered through nylon mesh with a pore size of 90 μm. Cell suspension was plated on T75 culture flask pretreated with poli-L-lysine. After attachment of the cells, the culture medium was changed to DMEM containing 10% FBS supplemented with antibiotics (1%) and fungizone (1%). Cultures were grown in a humidified atmosphere of 5% CO2/95% air at 37ºC. After 3 days, cells were exposed to 10 μM cytosine β-D arabino-furanoside for 24 h to inhibit proliferation of non-neuronal cells. The purity of neurons and possible contamination by astrocytes were assessed by immunofluorescence using antibodies anti-GFAP and anti-MAP-2. Under these conditions, 99% of the cells were neurons. Mixed cultures cells were not exposed to cytosine β-D arabino-furanoside allowing the proliferation of non-neuronal cells. Ten days after seeding approximately 60% of cells were astrocytes and 40% neurons. At this time, 5 μM Aβ1-42 (toxic) or Aβ 40-1 (control) were added and assays were performed at indicated times. Treatment of cultures with Aβ 40-1 did not produce any effects compared with cultures in the absence of any peptide (data not shown).
MTT assay
Cell viability of the cultures was determined by the MTT assay [15] . Neurons and/or astrocytes were plated in 96 well cultures. Aβ 40-1 (control) and Aβ peptides were added to wells during 24h. After cell treatments the medium was removed and the cortical cells were incubated with red free medium and MTT solution [0.5 mg/ml, prepared in phosphate buffer saline (PBS) solution] for 4 h at 37ºC. Finally the medium was removed and formazan particles were dissolved in dimethyl sulfoxide (DMSO). Cell viability, defined as the relative amount of MTT reduction was determined by spectrophotometry at 570 nm.
Caspase-3 activity assay
Caspase activity was performed with the Apo Alert CPP32/caspase 3 assay kit according to the manufacturer's protocol (CLONTECH, Palo Alto, CA). Adherent cells were collected, centrifuged and washed twice with ice-cold PBS and stored as a pellet at -80 ºC. Cell pellets were solubilised in lyses buffer and centrifuged to remove debris and samples containing equal amounts of protein were incubated with 50 μm N-acetyl-Asp-Glut-Val-Asp-AFC (7-amino-4-trifluoromethyl coumarin) 1h at 37ºC. The samples were analyzed using an enzyme-linked immunosorbent assay plate reader with excitation of 360 nm and emission of 530 nm.
Malondialdehyde determination
Malondialdehyde (MDA) levels were assessed by high-performance liquid chromatography. Cells were homogenized and centrifuged, and the supernatants collected and stored on ice. Samples were hydrolyzed by boiling in diluted phosphoric acid. MDA, one of the low-molecular weight end products formed by lipid-peroxidation, reacted with thiobarbituric acid (TBA) to form MDA-TBA adducts which were eluted with methanol-phosphate buffer to be quantified by spectrophotometry at 532 nm.
Western blot analysis
Cultured cells were treated with lysis buffer and then mechanically degraded to release the proteins. Protein concentration was determined using modified Lowry method [16] . Loading buffer (0.125 M Tris-HCl, pH 6.8, 2% SDS, 0.5% (v/v) 2-mercaptoethanol, 1% bromophenolblue and 19% glycerol) was added to protein sample and heated for 5 min at 95ºC. Proteins were separated on SDS-PAGE gels and transferred to nitrocellulose membranes in a humid environment using a transfer buffer (25 mM Tris, 190 mM glycine, 20% methanol). Membranes were blocked with 5% milk in TBS (0.05% and were incubated with primary antibodies overnight at 4ºC. Membranes were washed 3 times with wash buffer TBS-T (TBS, 0.2% Tween-20) and were incubated with a secondary anti-rabbit IgG or anti-mouse IgG (Cell Signalling Technologies Danvers, MA) antibody conjugated to the enzyme horseradish peroxidase (HRP) for 1 h. Membranes were washed three times and proteins were detected using the ECL method as specified by the manufacturer. Autoradiography signals were assessed using digital image system ImageQuant LAS 4000 (GE Healthcare).
Peroxide levels determination
To determine peroxide levels we used a modification of the method described by Barja et al. [16] . Cells were washed twice with PBS and then incubated at 37ºC with a PBS solution containing 0.1 mM homovanilic acid and 6 U/ml horseradish peroxidase. Incubation was stopped at 5 min with cold glycine buffer (2M) containing 50 mM EDTA and 2.2 M NaOH. Supernatant was measured by fluorescence (312 nm excitation and 420 nm emission).
Statistical methods
Values are expressed as mean ± S.D. Differences between groups were assessed by one-way analysis of variance (ANOVA). Statistical significance was accepted at P ≤ 0.05. Data sets in which F was significant were examined by a modified t-test.
Results
Astrocytes protect neurons from Aβ-induced cell death.
As a first step we evaluated Aβ-induced cell death in cultured neurons and/or astrocytes. As shown in Figure 1 , treatment with Aβ 1-42 peptide (5 μM 24 hours) caused a decrease in cell viability of about 50% compared with control neurons. However, treatment of astrocytes with the toxic peptide did not induce any significant changes in cell viability compared with control untreated astrocytes. Moreover, when neurons and astrocytes were mixed-cultures we did not detect neuron cell death after toxic peptide addition as compared with controls.
Aβ increases caspase 3 levels in neurons treated with Aβ toxic peptide.
In order to investigate if these changes were part of an ongoing apoptotic process, we evaluated the effect of toxic Aβ 1-42 treatment on activation of a late-effector caspase. In vitro activity of DEVDase caspase was assayed after treating cells with Aβ 1-42 toxic peptide, and Aβ 40-1 as a control peptide. As shown in Figure 2 , the presence of the toxic peptide resulted in almost a 3 times increase in DEVDase caspase activity in primary cultured neurons, without significant changes in astrocytes or in mixed-culture cells, demonstrating apoptosis induction only in isolated neurons. One of the receptor-mediated mechanisms linked to activation of late caspases involves mitochondrial dysfunction, characterized by release of cytochrome c and subsequent activation of caspase 9 [17] . As shown in Figure 2 , indeed Aβ1-42 causes cytochrome c release in cultured neurons.
Aβ increases lipid peroxidation in neurons in primary culture.
Aβ causes neurone cell death; likely by inducing caspases-dependent apoptosis (Figure 2) , we also measured if this toxicity w a s associated with oxidative stress. For this purpose MDA levels were measured as a marker of lipid peroxidation. Aβ 1-42 (5 µM x 24h) increased MDA levels in cultured neurons ( Figure 3 ) as compared to controls. However the presence of Aβ 1-42 did not modified either MDA levels in astrocytes or in mixed-culture cells (Figure 3 ). Only at higher concentrations of toxic peptide ≥ 20 µM we detected an increase of MDA levels in primary cultured astrocytes (data not shown). To know whether astrocytes in primary culture present oxidative stress, we determined peroxide levels. After 24 h of incubation with Aβ 1-42 , we detected an increase of H2O2 levels in astrocytes in primary culture. Moreover, we also observed an important increase of MnSOD protein expression induced by ROS in cultured astrocytes (Figure 5) , demonstrating an oxidative stress induction. We detect the nuclei-levels of p-65 protein, component of NF-κB in Figure 5 demonstrating an increase in p-65 protein expression in astrocytes after toxic peptide addition during 24 h. Furthermore, we noted a decrease in IκB protein level from cytoplasm astrocytes. Both results indicate that Aβ1-42 increases NF-κB protein expression in astrocytes. As mitochondrial biogenesis induction occurs, we determined the levels of TFAM and PGC-1 in the absence (control) and in the presence of Aβ 1-42 . Toxic peptide induces protein overexpression of TFAM and PGC-1 in astrocytes. TFAM and PGC-1 proteins are related with mitochondrial biogenesis in cells after mitochondrial stress. Figure 6 also shows a significant decrease in PPAR-γ (an anti-inflammatory protein) and SIRT-1 after treatment with Aβ1-42.
Discussion
The results of the present study show that Aβ 1-42 peptide diminishes cellular viability, increases apoptosis and lipid peroxidation in neurons but neither in astrocytes nor mixed-culture. These findings indicate a protective role of astrocytes on neurons against Aβ1-42 toxic peptide. The results also demonstrate that astrocytes increase mitochondrial biogenesis and MnSOD protein expression; both mechanisms can contribute to the protective role of astrocytes. Relationship between neurons and astrocytes will be important to understand brain development and/or neurodegeneration. In brain from AD patients both inflammation and oxidative stress are increased [17] , but their pathogenic significances remain unclear. Because anti-inflammatory therapy protects neurons against toxic substances [18] , keep down inflammation and oxidative stress processes could improve neurodegeneration in AD. It is known that astrocytes have nutritional and support functions to neurons but also astrocytes can protect them against oxidative stress and inflammation [19, 20] . This protective effect may become deleterious when the activation of astrocytes increases [21] . Our results indicate that Aβ1-42 significantly increases MDA levels in neurons in primary culture without any changes in primary culture of astrocytes and mixed culture. Since MDA indicates lipid peroxidation, a reduction in MDA levels in mixed cultures is consistent with a protective effect of astrocytes against lipid peroxidation.
The presence of astrocytes in the mixed cultures might protect neurons to inflammation and oxidative stress caused by Aβ1-42, as authors published for other toxic components [22] . Carrero et al. [23] suggest that reactive astrocytes might be mediated by pro-and/or inflammatory gene expression and NFκB increase, which would potentiate neuronal demise. In this study, Aβ peptide induces damage by simple injection affecting neurons, astrocytes and blood vessels. The differences with Carrero et al. could be due to the different methodology used. Our experiments, carried out in cultured cells, allow us to study the effects of Aβ peptide on neurons, astrocytes or mixed-cultures selectively. Thus we could assess whether the neuronal damage is caused by direct effect of Aβ1-42 peptide or by inflammation generated in other cells. Moreover, increase of p-65 protein expression in astrocytes observed in our study could not indicate a neuronal demise but probably a protection of neurons. Although there is evidence that inflammation promotes AD, certain inflammatory mediators may also improve AD [20] . Wyss Corey et al. published the role of astrocytes such as defence cells inside the brain, and indicating a phagocyte process of astrocytes to eliminate and destroy Aβ peptide [20] . Our previous study also demonstrated the anti-inflammatory effects of astrocytes after Aβ-induction and protection with genistein or estradiol [6] .
Furthermore, in cultured astrocytes we observed that Aβ1-42 upregulated MnSOD expression suggesting a possible antioxidant defence system that could protect neurons against oxidative damage scavenging ROS, such as occurs inside the brain [24] . Our results indicate that astrocytes protect neurons probably by an increase in mitochondrial biogenesis, obtaining better oxidative stress protection and perhaps producing control of inflammatory process. Increase reactive oxygen species is involved in mitochondrial DNA injury [9] . It is well known that TFAM induces mitochondrial DNA replication and maintenance [11] . In cultured SH-SY5Y cells, over-expression of TFAM diminished reactive oxygen species production and attenuated Aβ 1-42 -induced cell damage [25] . Accordingly, our results demonstrate an induction of p-65 (NF-κB) and over-expression of TFAM and PGC-1 after Aβ 1-42 peptide addition in astrocytes in primary culture. Data indicate that mitochondrial biogenesis can be involved in neuronal protection against Aβ 1-42 toxic peptide. These effects can be done by TFAM because over-expression of TFAM in astrocytes probably produces protection of mtDNA against Aβ 1-42 peptide. TFAM can protect mtDNA from oxidative stress and inflammation by covering the mtDNA region [11, 13] as well as maintaining mtDNA copy number [2 6 ]. Furthermore, TFAM could increase mitochondrial biogenesis controlling mitochondrial dysfunction by initiate mtDNA transcription [27] .
SIRT-1 has a role on deacetylate reactions of different proteins such as transcription factors involved in metabolic regulation, stress modulation, cell survival, aging and immune or inflammatory processes [28] . Expression of sirtuins is increased in caloric restriction of brain tissue [29] and a significant decrease in SIRT-1 protein has been noted in AD patients [30] . SIRT-1 modulates PGC-1 transcriptional expression and NF-κB activity in rat cardiac tissue [31] . Up or downregulation of PGC-1 determinates mitochondrial biogenesis through TFAM [32] . In our results, Aβ1-42 decreases SIRT-1 protein expression in cultured astrocytes which upregulates PGC-1 and TFAM resulting in augmentation of mitochondrial biogenesis. On the other hand we observed that Aβ 1-42 diminishes PPAR-γ expression leading to an increase of NF-κB expression. This factor promotes PGC-1 phosphorylation that raises TFAM resulting in mitochondrial biogenesis ( Figure 7 ). Taken together, our results indicate that Aβ 1-42 exposition induces mitochondrial biogenesis in cultured astrocytes. Astrocytes are involved in brain homeostasis, neural function, metabolic support to neurons and also in the synthesis of glutathione and its precursors [33] . The exact mechanisms as astrocytes protect neurons remain to be determined. Qin et al. have reported that mitochondrial biogenesis is altered in AD [34] . Because the presence of astrocytes prevents neuronal lipid peroxidation induced by Aβ1-42, we can hypothesize that increase of mitochondrial biogenesis in astrocytes supply high-energy demand to diminish free radical release induced by Aβ peptide. Therefore this mechanism could protect neurons against lipid peroxidation increase (Figure 7 ).
In conclusion, our results indicate that astrocytes may have a key role in protecting neurons against Aβ1-42 toxic peptide by increasing cell viability and mitochondrial biogenesis, obtaining better oxidative stress protection and perhaps modulating inflammatory processes. This might be a sign of a complex epigenetic process in Alzheimer's disease development.
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